{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:14:42Z","timestamp":1793218482769,"version":"4.5.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871507 and 81471389"],"award-info":[{"award-number":["81871507 and 81471389"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12974-019-1475-7","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T15:14:30Z","timestamp":1555514070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":148,"title":["Role of inflammation in depression relapse"],"prefix":"10.1186","volume":"16","author":[{"given":"Chun-Hong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Zhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Woelfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,17]]},"reference":[{"issue":"3","key":"1475_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11065-012-9199-9","volume":"22","author":"I Marchetti","year":"2012","unstructured":"Marchetti I, Koster EH, Sonuga-Barke EJ, De Raedt R. The default mode network and recurrent depression: a neurobiological model of cognitive risk factors. Neuropsychol Rev. 2012;22(3):229\u201351.","journal-title":"Neuropsychol Rev"},{"issue":"4","key":"1475_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.biopsych.2015.02.020","volume":"78","author":"JP Hamilton","year":"2015","unstructured":"Hamilton JP, Farmer M, Fogelman P, Gotlib IH. Depressive rumination, the default-mode network, and the dark matter of clinical neuroscience. Biol Psychiatry. 2015;78(4):224\u201330.","journal-title":"Biol Psychiatry"},{"issue":"7526","key":"1475_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/515180a","volume":"515","author":"K Smith","year":"2014","unstructured":"Smith K. Mental health: a world of depression. Nature. 2014;515(7526):181.","journal-title":"Nature."},{"issue":"11","key":"1475_CR4","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatr. 2006;163(11):1905\u201317.","journal-title":"Am J Psychiatr"},{"issue":"1","key":"1475_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/mpr.138","volume":"12","author":"L Andrade","year":"2003","unstructured":"Andrade L, Caraveo-Anduaga JJ, Berglund P, Bijl RV, De Graaf R, Vollebergh W, et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res. 2003;12(1):3\u201321 Erratum in: Int J Methods Psychiatr Res.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"8","key":"1475_CR6","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.cpr.2007.02.005","volume":"27","author":"SL Burcusa","year":"2007","unstructured":"Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev. 2007;27(8):959\u201385 Epub 2007 Mar 3.","journal-title":"Clin Psychol Rev"},{"issue":"3","key":"1475_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11126-015-9341-y","volume":"86","author":"O Johansson","year":"2015","unstructured":"Johansson O, Lundh LG, Bj\u00e4rehed J. 12-month outcome and predictors of recurrence in psychiatric treatment of depression: a retrospective study. Psychiatr Q. 2015;86(3):407\u201317.","journal-title":"Psychiatr Q"},{"issue":"2","key":"1475_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1037\/0033-295X.112.2.417","volume":"112","author":"SM Monroe","year":"2005","unstructured":"Monroe SM, Harkness KL. Life stress, the \u201ckindling\u201d hypothesis, and the recurrence of depression: considerations from a life stress perspective. Psychol Rev. 2005;112(2):417\u201345.","journal-title":"Psychol Rev"},{"issue":"4 Suppl","key":"1475_CR9","first-page":"1","volume":"157","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157(4 Suppl):1\u201345.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1475_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tins.2010.10.004","volume":"34","author":"PE Holtzheimer","year":"2011","unstructured":"Holtzheimer PE, Mayberg HS. Stuck in a rut: rethinking depression and its treatment. Trends Neurosci. 2011;34(1):1\u20139.","journal-title":"Trends Neurosci"},{"issue":"12","key":"1475_CR11","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1038\/npp.2011.151","volume":"36","author":"HD Schmidt","year":"2011","unstructured":"Schmidt HD, Shelton RC, Duman RS. Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology. 2011;36(12):2375\u201394.","journal-title":"Neuropsychopharmacology."},{"issue":"9","key":"1475_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/archpsyc.1991.01810330075011","volume":"48","author":"E Frank","year":"1991","unstructured":"Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48(9):851\u20135.","journal-title":"Arch Gen Psychiatry"},{"key":"1475_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","volume":"53","author":"JD Rosenblat","year":"2014","unstructured":"Rosenblat JD, Cha DS, Mansur RB, McIntyre RS. Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog Neuro-Psychopharmacol Biol Psychiatry. 2014;53:23\u201334.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1601","key":"1475_CR14","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1098\/rstb.2012.0212","volume":"367","author":"R Massart","year":"2012","unstructured":"Massart R, Mongeau R, Lanfumey L. Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression. Philos Trans R Soc Lond Ser B Biol Sci. 2012;367(1601):2485\u201394.","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"9","key":"1475_CR15","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/0269881117711708","volume":"31","author":"P Kopschina Feltes","year":"2017","unstructured":"Kopschina Feltes P, Doorduin J, Klein HC, Ju\u00e1rez-Orozco LE, Dierckx RA, Moriguchi-Jeckel CM, et al. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. J Psychopharmacol. 2017;31(9):1149\u201365.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"1475_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22\u201334.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1475_CR17","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.pnpbp.2010.06.020","volume":"35","author":"C Song","year":"2011","unstructured":"Song C, Wang H. Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2011;35(3):760\u20138.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1475_CR18","doi-asserted-by":"crossref","unstructured":"Woelfer M, Kasties V, Kahlfuss S, Walter M. The role of depressive subtypes within the neuroinflammation Hypothesis of Major Depressive Disorder. Neuroscience. 2019;403:93-110.","DOI":"10.1016\/j.neuroscience.2018.03.034"},{"issue":"1","key":"1475_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jad.2012.10.036","volume":"148","author":"LA Carvalho","year":"2013","unstructured":"Carvalho LA, Torre JP, Papadopoulos AS, Poon L, Juruena MF, Markopoulou K, et al. Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system. J Affect Disord. 2013;148(1):136\u201340.","journal-title":"J Affect Disord"},{"key":"1475_CR20","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1038\/tp.2012.8","volume":"2","author":"N Vogelzangs","year":"2012","unstructured":"Vogelzangs N, Duivis HE, Beekman AT, Kluft C, Neuteboom J, Hoogendijk W, et al. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry. 2012;2:e79.","journal-title":"Transl Psychiatry"},{"issue":"4","key":"1475_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","volume":"35","author":"RS Smith","year":"1991","unstructured":"Smith RS. The macrophage theory of depression. Med Hypotheses. 1991;35(4):298\u2013306.","journal-title":"Med Hypotheses"},{"issue":"11","key":"1475_CR22","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1176\/appi.ajp.2015.15020152","volume":"172","author":"JK Kiecolt-Glaser","year":"2015","unstructured":"Kiecolt-Glaser JK, Derry HM, Fagundes CP. Inflammation: depression fans the flames and feasts on the heat. Am J Psychiatr. 2015;172(11):1075\u201391.","journal-title":"Am J Psychiatr"},{"issue":"1","key":"1475_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1001\/jamapsychiatry.2015.1977","volume":"73","author":"M Jokela","year":"2016","unstructured":"Jokela M, Virtanen M, Batty GD, Kivimaki M. Inflammation and specific symptoms of depression. JAMA Psychiatry. 2016;73(1):87\u20138.","journal-title":"JAMA Psychiatry."},{"key":"1475_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.exger.2017.12.005","volume":"102","author":"KJ Smith","year":"2017","unstructured":"Smith KJ, Au B, Ollis L, Schmitz N. The association between C-reactive protein, Interleukin-6 and depression among older adults in the community: a systematic review and meta-analysis. Exp Gerontol. 2017;102:109\u201332.","journal-title":"Exp Gerontol"},{"issue":"1","key":"1475_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12888-018-1845-1","volume":"18","author":"C Yang","year":"2018","unstructured":"Yang C, Bosker FJ, Li J, Schoevers RA. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial. BMC Psychiatry. 2018;18(1):279.","journal-title":"BMC Psychiatry"},{"key":"1475_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/7854_2016_13","volume":"31","author":"JC Felger","year":"2017","unstructured":"Felger JC. The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications. Curr Top Behav Neurosci. 2017;31:199\u2013219.","journal-title":"Curr Top Behav Neurosci"},{"issue":"Pt C","key":"1475_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.pnpbp.2017.03.016","volume":"80","author":"P Galecki","year":"2018","unstructured":"Galecki P, Mossakowska-W\u00f3jcik J, Talarowska M. The anti-inflammatory mechanism of antidepressants-SSRIs, SNRIs. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;80(Pt C):291\u20134.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"6","key":"1475_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0004867417701996","volume":"51","author":"AL Lopresti","year":"2017","unstructured":"Lopresti AL. Cognitive behaviour therapy and inflammation: a systematic review of its relationship and the potential implications for the treatment of depression. Aust N Z J Psychiatry. 2017;51(6):565\u201382.","journal-title":"Aust N Z J Psychiatry"},{"issue":"Pt 6","key":"1475_CR29","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1042\/BST0341037","volume":"34","author":"VA Pavlov","year":"2006","unstructured":"Pavlov VA, Tracey KJ. Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem Soc Trans. 2006;34(Pt 6):1037\u201340.","journal-title":"Biochem Soc Trans"},{"key":"1475_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fpsyt.2018.00020","volume":"9","author":"J Kong","year":"2018","unstructured":"Kong J, Fang J, Park J, Li S, Rong P. Treating depression with transcutaneous auricular vagus nerve stimulation: state of the art and future perspectives. Front Psychiatry. 2018;9:20.","journal-title":"Front Psychiatry"},{"issue":"1","key":"1475_CR31","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/npp.2016.143","volume":"42","author":"JC Felger","year":"2017","unstructured":"Felger JC, Treadway MT. Inflammation effects on motivation and motor activity: role of dopamine. Neuropsychopharmacology. 2017;42(1):216\u201341.","journal-title":"Neuropsychopharmacology."},{"key":"1475_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neubiorev.2016.02.017","volume":"64","author":"W Swardfager","year":"2016","unstructured":"Swardfager W, Rosenblat JD, Benlamri M, McIntyre RS. Mapping inflammation onto mood: inflammatory mediators of anhedonia. Neurosci Biobehav Rev. 2016;64:148\u201366.","journal-title":"Neurosci Biobehav Rev"},{"issue":"11","key":"1475_CR33","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1089\/jwh.2017.6878","volume":"27","author":"MP Freeman","year":"2018","unstructured":"Freeman MP, Lee H, Savella GM, Sosinsky AZ, Marfurt SP, Murphy SK, et al. Predictors of depressive relapse in women undergoing infertility treatment. J Women's Health (Larchmt). 2018;27(11):1408\u201314.","journal-title":"J Women's Health (Larchmt)"},{"issue":"1","key":"1475_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.biopsych.2011.09.023","volume":"71","author":"WE Copeland","year":"2012","unstructured":"Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ. Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol Psychiatry. 2012;71(1):15\u201321.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1475_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.biopsych.2017.10.025","volume":"83","author":"DJ Stein","year":"2018","unstructured":"Stein DJ, Naud\u00e9 PJ, Berk M. Stress, depression, and inflammation: molecular and microglial mechanisms. Biol Psychiatry. 2018;83(1):5\u20136.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"1475_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000119472","volume":"24","author":"M Maes","year":"1990","unstructured":"Maes M, Bosmans E, Suy E, Vandervorst C, De Jonckheere C, Raus J. Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology. 1990;24(3):115\u201320.","journal-title":"Neuropsychobiology."},{"issue":"1","key":"1475_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1124\/pr.113.008144","volume":"66","author":"AK Walker","year":"2013","unstructured":"Walker AK, Kavelaars A, Heijnen CJ, Dantzer R. Neuroinflammation and comorbidity of pain and depression. Pharmacol Rev. 2013;66(1):80\u2013101.","journal-title":"Pharmacol Rev"},{"issue":"2","key":"1475_CR38","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2174\/1570159X15666170828163048","volume":"16","author":"M Adzic","year":"2018","unstructured":"Adzic M, Brkic Z, Mitic M, Francija E, Jovicic MJ, Radulovic J, et al. Therapeutic strategies for treatment of inflammation-related depression. Curr Neuropharmacol. 2018;16(2):176\u2013209.","journal-title":"Curr Neuropharmacol"},{"key":"1475_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pnpbp.2015.11.012","volume":"66","author":"R Haapakoski","year":"2016","unstructured":"Haapakoski R, Ebmeier KP, Alenius H, Kivim\u00e4ki M. Innate and adaptive immunity in the development of depression: an update on current knowledge and technological advances. Prog Neuro-Psychopharmacol Biol Psychiatry. 2016;66:63\u201372.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1475_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jad.2014.07.032","volume":"169","author":"JJ Young","year":"2014","unstructured":"Young JJ, Bruno D, Pomara N. A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord. 2014;169:15\u201320.","journal-title":"J Affect Disord"},{"issue":"5","key":"1475_CR41","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanct\u00f4t KL. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446\u201357.","journal-title":"Biol Psychiatry"},{"issue":"12","key":"1475_CR42","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21(12):1696\u2013709.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"1475_CR43","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3325\/cmj.2013.54.453","volume":"54","author":"R Topic","year":"2013","unstructured":"Topic R, Milicic D, Stimac Z, Loncar M, Velagic V, Marcinko D, et al. Somatic comorbidity, metabolic syndrome, cardiovascular risk, and CRP in patients with recurrent depressive disorders. Croat Med J. 2013;54(5):453\u20139.","journal-title":"Croat Med J"},{"issue":"3","key":"1475_CR44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1017\/S0033291708003723","volume":"39","author":"D Gimeno","year":"2009","unstructured":"Gimeno D, Kivim\u00e4ki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med. 2009;39(3):413\u201323.","journal-title":"Psychol Med"},{"issue":"8","key":"1475_CR45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nri2587","volume":"9","author":"GM Barton","year":"2009","unstructured":"Barton GM, Kagan JC. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol. 2009;9(8):535\u201342.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"1475_CR46","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.euroneuro.2017.04.001","volume":"27","author":"CM Pariante","year":"2017","unstructured":"Pariante CM. Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation. Eur Neuropsychopharmacol. 2017;27(6):554\u20139.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"1475_CR47","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1176\/appi.ajp.160.10.1890","volume":"160","author":"Z Bhagwagar","year":"2003","unstructured":"Bhagwagar Z, Hafizi S, Cowen PJ. Increase in concentration of waking salivary cortisol in recovered patients with depression. Am J Psychiatry. 2003;160(10):1890\u20131.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1475_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbi.2006.08.009","volume":"21","author":"TW Pace","year":"2007","unstructured":"Pace TW, Hu F, Miller AH. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun. 2007;21(1):9\u201319.","journal-title":"Brain Behav Immun"},{"key":"1475_CR49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1749-6632.2009.04984.x","volume":"1179","author":"TW Pace","year":"2009","unstructured":"Pace TW, Miller AH. Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann N Y Acad Sci. 2009;1179:86\u2013105.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1475_CR50","doi-asserted-by":"publisher","first-page":"437","DOI":"10.12740\/PP\/76863","volume":"52","author":"P Ga\u0142ecki","year":"2018","unstructured":"Ga\u0142ecki P, Talarowska M. Inflammatory theory of depression. Psychiatr Pol. 2018;52(3):437\u201347.","journal-title":"Psychiatr Pol"},{"issue":"2","key":"1475_CR51","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","volume":"130","author":"L Capuron","year":"2011","unstructured":"Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther. 2011;130(2):226\u201338.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1475_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.102.034439","volume":"303","author":"R Schwarcz","year":"2002","unstructured":"Schwarcz R, Pellicciari R. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther. 2002;303(1):1\u201310.","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"1475_CR53","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2174\/1381612822999160104143932","volume":"22","author":"G Anderson","year":"2016","unstructured":"Anderson G. Editorial: The kynurenine and melatonergic pathways in psychiatric and CNS disorders. Curr Pharm Des. 2016;22(8):947\u20138.","journal-title":"Curr Pharm Des"},{"issue":"9","key":"1475_CR54","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732\u201341.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1475_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-3223(03)00473-6","volume":"55","author":"ES Brown","year":"2004","unstructured":"Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: does cortisol play a role? Biol Psychiatry. 2004;55(1):1\u20139.","journal-title":"Biol Psychiatry"},{"issue":"11","key":"1475_CR56","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/gps.2672","volume":"26","author":"GS Alexopoulos","year":"2011","unstructured":"Alexopoulos GS, Morimoto SS. The inflammation hypothesis in geriatric depression. Int J Geriatr Psychiatry. 2011;26(11):1109\u201318.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1475_CR57","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.12659\/MSM.893176","volume":"21","author":"P Ga\u0142ecki","year":"2015","unstructured":"Ga\u0142ecki P, Talarowska M, Anderson G, Berk M, Maes M. Mechanisms underlying neurocognitive dysfunctions in recurrent major depression. Med Sci Monit. 2015;21:1535\u201347.","journal-title":"Med Sci Monit"},{"key":"1475_CR58","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fncel.2018.00306","volume":"12","author":"L Zhang","year":"2018","unstructured":"Zhang L, Zhang J, You Z. Switching of the microglial activation phenotype is a possible treatment for depression disorder. Front Cell Neurosci. 2018;12:306.","journal-title":"Front Cell Neurosci"},{"issue":"5134","key":"1475_CR59","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.7901908","volume":"262","author":"JT Coyle","year":"1993","unstructured":"Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993;262(5134):689\u201395.","journal-title":"Science."},{"issue":"3","key":"1475_CR60","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","volume":"72","author":"E Setiawan","year":"2015","unstructured":"Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry. 2015;72(3):268\u201375.","journal-title":"JAMA Psychiatry."},{"issue":"10","key":"1475_CR61","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1007\/s11064-017-2270-4","volume":"42","author":"L Tong","year":"2017","unstructured":"Tong L, Gong Y, Wang P, Hu W, Wang J, Chen Z, et al. Microglia loss contributes to the development of major depression induced by different types of chronic stresses. Neurochem Res. 2017;42(10):2698\u2013711.","journal-title":"Neurochem Res"},{"issue":"11","key":"1475_CR62","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/sj.mp.4002006","volume":"12","author":"N M\u00fcller","year":"2007","unstructured":"M\u00fcller N, Schwarz MJ. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry. 2007;12(11):988\u20131000.","journal-title":"Mol Psychiatry"},{"issue":"10","key":"1475_CR63","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tins.2015.08.001","volume":"38","author":"R Yirmiya","year":"2015","unstructured":"Yirmiya R, Rimmerman N, Reshef R. Depression as a microglial disease. Trends Neurosci. 2015;38(10):637\u201358.","journal-title":"Trends Neurosci"},{"issue":"Pt A","key":"1475_CR64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pnpbp.2016.04.013","volume":"79","author":"ES Wohleb","year":"2017","unstructured":"Wohleb ES, Delpech JC. Dynamic cross-talk between microglia and peripheral monocytes underlies stress-induced neuroinflammation and behavioral consequences. Prog Neuro-Psychopharmacol Biol Psychiatry. 2017;79(Pt A):40\u20138.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1475_CR65","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3389\/fnins.2014.00447","volume":"8","author":"ES Wohleb","year":"2015","unstructured":"Wohleb ES, McKim DB, Sheridan JF, Godbout JP. Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior. Front Neurosci. 2015;8:447.","journal-title":"Front Neurosci"},{"key":"1475_CR66","doi-asserted-by":"publisher","unstructured":"Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, et al. Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatorydisease. Epidemiol Psychiatr Sci. 2017;3:1-10. https:\/\/doi.org\/10.1017\/S2045796017000579 .","DOI":"10.1017\/S2045796017000579"},{"key":"1475_CR67","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.neubiorev.2018.05.031","volume":"92","author":"D Arnone","year":"2018","unstructured":"Arnone D, Saraykar S, Salem H, Teixeira AL, Dantzer R, Selvaraj S. Role of Kynurenine pathway and its metabolites in mood disorders: a systematic review and meta-analysis of clinical studies. Neurosci Biobehav Rev. 2018;92:477\u201385.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"1475_CR68","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/15622975.2016.1155746","volume":"18","author":"HH Chang","year":"2017","unstructured":"Chang HH, Wang TY, Lee IH, Lee SY, Chen KC, Huang SY, et al. C-reactive protein: a differential biomarker for major depressive disorder and bipolar II disorder. World J Biol Psychiatry. 2017;18(1):63\u201370.","journal-title":"World J Biol Psychiatry"},{"issue":"3","key":"1475_CR69","doi-asserted-by":"publisher","first-page":"e91076","DOI":"10.1371\/journal.pone.0091076","volume":"9","author":"TR Powell","year":"2014","unstructured":"Powell TR, McGuffin P, D'Souza UM, Cohen-Woods S, Hosang GM, Martin C, et al. Putative transcriptomic biomarkers in the inflammatory cytokine pathway differentiate major depressive disorder patients from control subjects and bipolar disorder patients. PLoS One. 2014;9(3):e91076.","journal-title":"PLoS One"},{"key":"1475_CR70","doi-asserted-by":"crossref","unstructured":"Maglanoc LA, Landr\u00f8 NI, Jonassen R, Kaufmann T, C\u00f3rdova-Palomera A, Hilland E, et al. Data-driven clustering reveals a link between symptoms and functional brain connectivity in depression. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4(1):16-26.","DOI":"10.1016\/j.bpsc.2018.05.005"},{"issue":"1","key":"1475_CR71","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nm.4246","volume":"23","author":"AT Drysdale","year":"2017","unstructured":"Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, et al. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med. 2017;23(1):28\u201338.","journal-title":"Nat Med"},{"issue":"12","key":"1475_CR72","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/mp.2012.105","volume":"17","author":"S Kapur","year":"2012","unstructured":"Kapur S, Phillips AG, Insel TR. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry. 2012;17(12):1174\u20139.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"1475_CR73","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.neuron.2014.01.027","volume":"81","author":"J Flint","year":"2014","unstructured":"Flint J, Kendler KS. The genetics of major depression. Neuron. 2014;81(3):484\u2013503.","journal-title":"Neuron."},{"issue":"11","key":"1475_CR74","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1055\/a-0628-7260","volume":"190","author":"F Brandl","year":"2018","unstructured":"Brandl F, Meng C, Zimmer C, Sorg C. The role of brain connectome imaging in the estimation of depressive relapse risk. Rofo. 2018;190(11):1036\u201343.","journal-title":"Rofo."},{"issue":"1\u20132","key":"1475_CR75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jad.2011.03.049","volume":"138","author":"E Bora","year":"2012","unstructured":"Bora E, Fornito A, Pantelis C, Y\u00fccel M. Gray matter abnormalities in major depressive disorder: a meta-analysis of voxel based morphometry studies. J Affect Disord. 2012;138(1\u20132):9\u201318.","journal-title":"J Affect Disord"},{"key":"1475_CR76","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1192\/bjp.bp.112.116228","volume":"202","author":"M Serra-Blasco","year":"2013","unstructured":"Serra-Blasco M, Portella MJ, G\u00f3mez-Ans\u00f3n B, de Diego-Adeli\u00f1o J, Vives-Gilabert Y, Puigdemont D, et al. Effects of illness duration and treatment resistance on grey matter abnormalities in major depression. Br J Psychiatry. 2013;202:434\u201340.","journal-title":"Br J Psychiatry"},{"issue":"3","key":"1475_CR77","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.biopsych.2014.06.018","volume":"77","author":"MT Treadway","year":"2015","unstructured":"Treadway MT, Waskom ML, Dillon DG, Holmes AJ, Park MT, Chakravarty MM, et al. Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortexin major depression. Biol Psychiatry. 2015;77(3):285\u201394.","journal-title":"Biol Psychiatry"},{"issue":"7","key":"1475_CR78","doi-asserted-by":"publisher","first-page":"e102692","DOI":"10.1371\/journal.pone.0102692","volume":"9","author":"M Stratmann","year":"2014","unstructured":"Stratmann M, Konrad C, Kugel H, Krug A, Sch\u00f6ning S, Ohrmann P, et al. Insular and hippocampal gray matter volume reductions in patients with major depressive disorder. PLoS One. 2014;9(7):e102692.","journal-title":"PLoS One"},{"issue":"Pt 2","key":"1475_CR79","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/brain\/awt290","volume":"137","author":"C Meng","year":"2014","unstructured":"Meng C, Brandl F, Tahmasian M, Shao J, Manoliu A, Scherr M, et al. Aberrant topology of striatum\u2019s connectivity is associated with the number of episodes in depression. Brain. 2014;137(Pt 2):598\u2013609.","journal-title":"Brain."},{"issue":"5","key":"1475_CR80","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.biopsych.2006.09.020","volume":"62","author":"MD Greicius","year":"2007","unstructured":"Greicius MD, Flores BH, Menon V, Glover GH, Solvason HB, Kenna H, et al. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry. 2007;62(5):429\u201337.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"1475_CR81","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1017\/S0033291715002615","volume":"46","author":"RH Jacobs","year":"2016","unstructured":"Jacobs RH, Barba A, Gowins JR, Klumpp H, Jenkins LM, Mickey BJ, et al. Decoupling of the amygdala to other salience network regions in adolescent-onset recurrent major depressive disorder. Psychol Med. 2016;46(5):1055\u201367.","journal-title":"Psychol Med"},{"issue":"6","key":"1475_CR82","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/mp.2015.69","volume":"21","author":"L Schmaal","year":"2016","unstructured":"Schmaal L, Veltman DJ, van Erp TG, S\u00e4mann PG, Frodl T, Jahanshad N, et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry. 2016;21(6):806\u201312.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"1475_CR83","doi-asserted-by":"publisher","first-page":"e009510","DOI":"10.1136\/bmjopen-2015-009510","volume":"6","author":"RJ Mocking","year":"2016","unstructured":"Mocking RJ, Figueroa CA, Rive MM, Geugies H, Servaas MN, Assies J, et al. Vulnerability for new episodes in recurrent major depressive disorder: protocol for the longitudinal DELTA-neuroimaging cohort study. BMJ Open. 2016;6(3):e009510.","journal-title":"BMJ Open"},{"issue":"11","key":"1475_CR84","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/jamapsychiatry.2015.1813","volume":"72","author":"KE Lythe","year":"2015","unstructured":"Lythe KE, Moll J, Gethin JA, Workman CI, Green S, Lambon Ralph MA, et al. Self-blame-selective hyperconnectivity between anterior temporal and subgenual cortices and prediction of recurrent depressive episodes. JAMA Psychiatry. 2015;72(11):1119\u201326.","journal-title":"JAMA Psychiatry"},{"key":"1475_CR85","first-page":"1","volume":"8","author":"CI Workman","year":"2016","unstructured":"Workman CI, Lythe KE, McKie S, Moll J, Gethin JA, Deakin JF, et al. A novel resting-state functional magnetic resonance imaging signature of resilience to recurrent depression. Psychol Med. 2016;8:1\u201311.","journal-title":"Psychol Med"},{"issue":"5","key":"1475_CR86","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1001\/jamapsychiatry.2018.0123","volume":"75","author":"D Zaremba","year":"2018","unstructured":"Zaremba D, Dohm K, Redlich R, Grotegerd D, Strojny R, Meinert S, et al. Association of brain cortical changes with relapse in patients with major depressive disorder. JAMA Psychiatry. 2018;75(5):484\u201392.","journal-title":"JAMA Psychiatry."},{"issue":"6","key":"1475_CR87","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jamapsychiatry.2015.0071","volume":"72","author":"RH Kaiser","year":"2015","unstructured":"Kaiser RH, Andrews-Hanna JR, Wager TD, Pizzagalli DA. Large-scale network dysfunction in major depressive disorder: a meta-analysis of resting-state functional connectivity. JAMA Psychiatry. 2015;72(6):603\u201311.","journal-title":"JAMA Psychiatry"},{"key":"1475_CR88","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.neubiorev.2015.07.014","volume":"56","author":"PC Mulders","year":"2015","unstructured":"Mulders PC, van Eijndhoven PF, Schene AH, Beckmann CF, Tendolkar I. Resting-state functional connectivity in major depressive disorder: a review. Neurosci Biobehav Rev. 2015;56:330\u201344.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"1475_CR89","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","volume":"150","author":"V Valkanova","year":"2013","unstructured":"Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord. 2013;150(3):736\u201344.","journal-title":"J Affect Disord"},{"issue":"7","key":"1475_CR90","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.bbi.2009.04.011","volume":"23","author":"JC Stewart","year":"2009","unstructured":"Stewart JC, Rand KL, Muldoon MF, Kamarck TW. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun. 2009;23(7):936\u201344.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"1475_CR91","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/mp.2009.124","volume":"16","author":"J Shi","year":"2011","unstructured":"Shi J, Potash JB, Knowles JA, Weissman MM, Coryell W, Scheftner WA, et al. Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry. 2011;16(2):193\u2013201.","journal-title":"Mol Psychiatry"},{"issue":"10","key":"1475_CR92","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1176\/appi.ajp.157.10.1552","volume":"157","author":"PF Sullivan","year":"2000","unstructured":"Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157(10):1552\u201362.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"1475_CR93","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s00429-014-0782-0","volume":"220","author":"JD Kruschwitz","year":"2015","unstructured":"Kruschwitz JD, Walter M, Varikuti D, Jensen J, Plichta MM, Haddad L, et al. 5-HTTLPR\/rs25531 polymorphism and neuroticism are linked by resting state functional connectivity of amygdala and fusiform gyrus. Brain Struct Funct. 2015;220(4):2373\u201385.","journal-title":"Brain Struct Funct"},{"issue":"1\u20133","key":"1475_CR94","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jad.2013.02.002","volume":"149","author":"CH Liu","year":"2013","unstructured":"Liu CH, Ma X, Wu X, Fan TT, Zhang Y, Zhou FC, et al. Resting-state brain activity in major depressive disorder patients and their siblings. J Affect Disord. 2013;149(1\u20133):299\u2013306.","journal-title":"J Affect Disord"},{"issue":"4","key":"1475_CR95","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.4088\/JCP.15m10022","volume":"78","author":"CH Liu","year":"2017","unstructured":"Liu CH, Ma X, Zhen Y, Song LP, Jing B, Lu HY, et al. Decreased resting-state activity in the precuneus is associated with depressive episodes in recurrent depression. J Clin Psychiatry. 2017;78(4):e372\u201382.","journal-title":"J Clin Psychiatry"},{"key":"1475_CR96","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fnhum.2013.00930","volume":"7","author":"A Manoliu","year":"2014","unstructured":"Manoliu A, Meng C, Brandl F, Doll A, Tahmasian M, Scherr M, et al. Insular dysfunction within the salience network is associated with severity of symptoms and aberrant inter-network connectivity in major depressive disorder. Front Hum Neurosci. 2014;7:930.","journal-title":"Front Hum Neurosci"},{"issue":"24","key":"1475_CR97","doi-asserted-by":"publisher","first-page":"11020","DOI":"10.1073\/pnas.1000446107","volume":"107","author":"YI Sheline","year":"2010","unstructured":"Sheline YI, Price JL, Yan Z, Mintun MA. Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc Natl Acad Sci U S A. 2010;107(24):11020\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1475_CR98","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/mp.2015.168","volume":"21","author":"JC Felger","year":"2016","unstructured":"Felger JC, Li Z, Haroon E, Woolwine BJ, Jung MY, Hu X, et al. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry. 2016;21(10):1358\u201365.","journal-title":"Mol Psychiatry"},{"key":"1475_CR99","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbi.2015.11.003","volume":"53","author":"TB Meier","year":"2016","unstructured":"Meier TB, Drevets WC, Wurfel BE, Ford BN, Morris HM, Victor TA, et al. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder. Brain Behav Immun. 2016;53:39\u201348.","journal-title":"Brain Behav Immun"},{"key":"1475_CR100","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1038\/tp.2012.14","volume":"2","author":"T Frodl","year":"2012","unstructured":"Frodl T, Carballedo A, Hughes MM, Saleh K, Fagan A, Skokauskas N, et al. Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder. Transl Psychiatry. 2012;2:e88.","journal-title":"Transl Psychiatry"},{"issue":"2","key":"1475_CR101","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/PSY.0b013e31820ad12b","volume":"73","author":"C Stetler","year":"2011","unstructured":"Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med. 2011;73(2):114\u201326.","journal-title":"Psychosom Med"},{"key":"1475_CR102","doi-asserted-by":"publisher","unstructured":"Liang S, Wu X, Hu X, Wang T, Jin F. Recognizing depression from the microbiota-gut-brain axis. Int J Mol Sci. 2018;19(6). https:\/\/doi.org\/10.3390\/ijms19061592 .","DOI":"10.3390\/ijms19061592"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1475-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-019-1475-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1475-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:39:49Z","timestamp":1721176789000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-019-1475-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1475"],"URL":"https:\/\/doi.org\/10.1186\/s12974-019-1475-7","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,17]]},"assertion":[{"value":"22 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"90"}}